اخبار و اعلانات

 آمار

تعداد نشریات284
تعداد نشریات سازمان82
تعداد شماره‌ها3,079
تعداد مقالات34,346
تعداد مشاهده مقاله47,592,318
تعداد دریافت فایل اصل مقاله78,602,977
Khamees, H. H, Fahad, M. A. (1402). Impact of ABO Blood Group, Hematological, and Biochemical Abnormalities on Incidence of Patients Infected with COVID-19. سامانه مدیریت نشریات علمی, 78(4), 1193-1201. doi: 10.32592/ARI.2023.78.4.1193
H. H Khamees; M. A Fahad. "Impact of ABO Blood Group, Hematological, and Biochemical Abnormalities on Incidence of Patients Infected with COVID-19". سامانه مدیریت نشریات علمی, 78, 4, 1402, 1193-1201. doi: 10.32592/ARI.2023.78.4.1193
Khamees, H. H, Fahad, M. A. (1402). 'Impact of ABO Blood Group, Hematological, and Biochemical Abnormalities on Incidence of Patients Infected with COVID-19', سامانه مدیریت نشریات علمی, 78(4), pp. 1193-1201. doi: 10.32592/ARI.2023.78.4.1193
Khamees, H. H, Fahad, M. A. Impact of ABO Blood Group, Hematological, and Biochemical Abnormalities on Incidence of Patients Infected with COVID-19. سامانه مدیریت نشریات علمی, 1402; 78(4): 1193-1201. doi: 10.32592/ARI.2023.78.4.1193

Impact of ABO Blood Group, Hematological, and Biochemical Abnormalities on Incidence of Patients Infected with COVID-19

Archives of Razi Institute
مقاله 5، دوره 78، شماره 4، مهر و آبان 2023، صفحه 1193-1201    اصل مقاله (303.85 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.32592/ARI.2023.78.4.1193
نویسندگان
H. H Khamees1؛ M. A Fahad* 2
1Medical Laboratory Techniques Department, Dijlah University College, Baghdad, Iraq
2Forensic Evidences Department, Al Salam university College, Baghdad, Iraq
چکیده
This study aimed to investigate the relationship between blood types and COVID-19 susceptibility and explore changes in blood variables, as well as their relationship with the occurrence of COVID-19. SARS-CoV-2 is a pandemic that has affected people’s health and the global financial system. Since the initial confirmed case of COVID-19, people have been influenced worldwide with varying manifestations. Moreover, researchers have illustrated a link between ABO blood types and COVID-19 susceptibility and incidence. Research has also shown that ABO blood groups might play a role in estimating COVID-19 susceptibility and death. Our analysis revealed that blood type O might probably reduce vulnerability to the SARS-CoV-2 illness. On the contrary, people with blood type A are at a higher risk of SARS-CoV-2 infection. This study also evaluated liver biomarkers among COVID-19 patients, revealing significant abnormalities in the levels of alanine amino transferees, aspartate amino transferees, gamma-glutamyl transferees, and total bilirubin.
کلیدواژه‌ها
Blood cells؛ COVID-19؛ Enzymes؛ Infection؛ Liver tests؛ Virus
سایر فایل های مرتبط با مقاله
مراجع
  1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.
  2. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol. 2020;190(1):24-7.
  3. Gerard C, Maggipinto G, Minon JM. COVID-19 and ABO blood group: another viewpoint. Br J Haematol. 2020;190(2):e93-e4.
  4. Branch DR. Blood groups and susceptibility to virus infection: new developments. Curr Opin Hematol. 2010;17(6):558-64.
  5. Hosseini SM, Feng JJ. How malaria parasites reduce the deformability of infected red blood cells. Biophys J. 2012;103(1):1-10.
  6. Cheng Y, Cheng G, Chui CH, Lau FY, Chan PKS, Ng MHL, et al. ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome. JAMA. 2005;293(12):1447-51.
  7. Cooling L. Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev. 2015;28(3):801-70.
  8. Guillon P, Clement M, Sebille V, Rivain JG, Chou CF, Ruvoen-Clouet N, et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008;18(12):1085-93.
  9. Waris A, Din M, Khalid A, Abbas Lail R, Shaheen A, Khan N, et al. Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience. J Clin Lab Anal. 2021;35(6):e23809.
  10. Esmaeili Dooki M, Mehrabani S, Sorkhi H, Nikpour M, Tabatabaie M, Mohammadi M, et al. COVID-19 and Digestive System in Children: A Retrospective Study. Arch Iran Med. 2020;23(11):782-6.
  11. Hall P, Cash J. What is the real function of the liver 'function' tests? Ulster Med J. 2012;81(1):30-6.
  12. SAS S. Statistical Analysis System, User’s Guide. Statistical. Version 9. SAS Inst Inc Cary NC USA. 2012.
  13. Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Deng Y, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020;96:131-5.
  14. Goker H, Aladag Karakulak E, Demiroglu H, Ayaz Ceylan CM, Buyukasik Y, Inkaya AC, et al. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci. 2020;50(4):679-83.
  15. Hoiland RL, Fergusson NA, Mitra AR, Griesdale DEG, Devine DV, Stukas S, et al. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv. 2020;4(20):4981-9.
  16. Abdollahi A, Mahmoudi-Aliabadi M, Mehrtash V, Jafarzadeh B, Salehi M. The Novel Coronavirus SARS-CoV-2 Vulnerability Association with ABO/Rh Blood Types. Iran J Pathol. 2020;15(3):156-60.
  17. Boudin L, Janvier F, Bylicki O, Dutasta F. ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults. Haematologica. 2020;105(12):2841-3.
  18. Dzik S, Eliason K, Morris EB, Kaufman RM, North CM. COVID-19 and ABO blood groups. Transfusion. 2020;60(8):1883-4.
  19. Garg I, Srivastava S, Dogra V, Bargotya M, Bhattar S, Gupta U, et al. Potential association of COVID-19 and ABO blood group: An Indian study. Microb Pathog. 2021;158:105008.
  20. Kabrah SM, Kabrah AM, Flemban AF, Abuzerr S. Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection. Transfus Apher Sci. 2021;60(4):103169.
  21. Kim Y, Latz CA, DeCarlo CS, Lee S, Png CM, Kibrik P, et al., editors. Relationship between blood type and outcomes following COVID-19 infection. Seminars in Vascular Surgery; 2021: Elsevier.
  22. Levi JE, Telles PR, Scrivani H, Oliveira F, Vieira L, Dias C, et al. Lack of association between ABO blood groups and susceptibility to SARS-CoV-2 infection. Hematology, Transfusion Cell Therapy. 2020;42:541.
  23. Liu N, Zhang T, Ma L, Zhang H, Wang H, Wei W, et al. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. Blood Rev. 2021;48:100785.
  24. Samra S, Habeb M, Nafae R. ABO groups can play a role in susceptibility and severity of COVID-19. Egypt J Bronchol. 2021;15(1):9.
  25. Zhang Y, Garner R, Salehi S, La Rocca M, Duncan D. Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies. Ann Hematol. 2021;100(5):1123-32.
  26. Zietz M, Zucker J, Tatonetti NP. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv : the preprint server for health sciences. 2020.
  27. Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, et al. Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord. 2020;20(1):373.
  28. Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152.
  29. Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China. JAMA Netw Open. 2020;3(4):e205619.
  30. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8.
  31. Fan BE. Hematologic parameters in patients with COVID-19 infection: a reply. 2020;95(8):E215-E.
  32. Pozdnyakova O, Connell NT, Battinelli EM, Connors JM, Fell G, Kim AS. Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection. Am J Clin Pathol. 2021;155(3):364-75.
  33. Watanabe A, Yoneda M, Ikeda F, Terao-Muto Y, Sato H, Kai C. CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells. J Virol. 2010;84(9):4183-93.
  34. Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205-8.
  35. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol. 2002;169(8):4288-97.
  36. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762-8.
  37. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
  38. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
  39. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145-8.
  40. Yuan X, Huang W, Ye B, Chen C, Huang R, Wu F, et al. Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol. 2020;112(4):553-9.
  41. Mei Y, Weinberg SE, Zhao L, Frink A, Qi C, Behdad A, et al. Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza. EClinicalMedicine. 2020;26:100475.
  42. O'Connor T, Santaniello S, Javidi B. COVID-19 detection from red blood cells using highly comparative time-series analysis (HCTSA) in digital holographic microscopy. Opt Express. 2022;30(2):1723-36.
  43. O'Connor T, Shen JB, Liang BT, Javidi B. Digital holographic deep learning of red blood cells for field-portable, rapid COVID-19 screening. Opt Lett. 2021;46(10):2344-7.
  44. Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med. 2020;8(9):593.
  45. Slomka A, Kowalewski M, Zekanowska E. Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations. Pathogens. 2020;9(6).
  46. Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, et al. Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021;73(3):890-900.
  47. Herta T, Berg T. COVID-19 and the liver - Lessons learned. Liver Int. 2021;41(1):1-8.
  48. Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, et al. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology. 2020;72(2):389-98.
  49. Shao T, Tong Y, Lu S, Jeyarajan AJ, Su F, Dai J, et al. Gamma-Glutamyltransferase Elevation Is Frequent in Patients With COVID-19: A Clinical Epidemiologic Study. Hepatol Commun. 2020;4(12):1744-50.
  50. Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, et al. Liver injury in COVID-19: clinical features and treatment management. Virol J. 2021;18(1):121.
  51. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. 2020:2020.02.03.931766.
  52. Parohan M, Yaghoubi S, Seraji A. Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies. Hepatol Res. 2020;50(8):924-35.
  53. Chen W, Liu H, Yang G, Wang W, Liu Q, Huang C, et al. Effect of direct bilirubin level on clinical outcome and prognoses in severely/critically ill patients with COVID-19. Frontiers in medicine. 2022;9:843505.
  54. Paliogiannis P, Zinellu A. Bilirubin levels in patients with mild and severe Covid-19: A pooled analysis. Liver Int. 2020;40(7):1787-8.
  1. Yadav DK, Singh A, Zhang Q, Bai X, Zhang W, Yadav RK, et al. Involvement of liver in COVID-19: systematic review and meta-analysis. Gut. 2021;70(4):807-9.
  2. McDonagh AF. Controversies in bilirubin biochemistry and their clinical relevance. Semin Fetal Neonatal Med. 2010;15(3):141-7.
آمار
تعداد مشاهده مقاله: 2,627
تعداد دریافت فایل اصل مقاله: 8,223


counter
سامانه مدیریت نشریات علمی. طراحی و پیاده سازی از سیناوب